These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18317248)

  • 1. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
    Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
    Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
    Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
    Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease.
    Bruno E; Quattrocchi G; Nicoletti A; Le Pira F; Maci T; Mostile G; Andreoli V; Quattrone A; Zappia M
    Neurosci Lett; 2010 Sep; 482(2):112-6. PubMed ID: 20637261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
    Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
    Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer's disease in Chengdu area].
    Tang MN; Zhang ZX; Han HY; Liu XH; Shen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):176-8. PubMed ID: 15079806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.
    Christoforidis M; Schober R; Krohn K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):11-9. PubMed ID: 15634227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
    Wang CH; Zhou X; Zhou GD; Han DF; Zheng F
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):554-8. PubMed ID: 15144588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
    Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
    Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
    Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.